BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33439552)

  • 1. Genetic analysis of the CITED2 gene promoter in isolated and sporadic congenital ventricular septal defects.
    Zheng SQ; Chen HX; Liu XC; Yang Q; He GW
    J Cell Mol Med; 2021 Feb; 25(4):2254-2261. PubMed ID: 33439552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of variants of
    Zheng SQ; Chen HX; Liu XC; Yang Q; He GW
    Am J Physiol Cell Physiol; 2021 Sep; 321(3):C443-C452. PubMed ID: 34260301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Point Mutations of CITED2 Gene Are Associated with Non-familial Congenital Heart Disease (CHD) in Sporadic Pediatric Patients.
    Dianatpour S; Khatami M; Heidari MM; Hadadzadeh M
    Appl Biochem Biotechnol; 2020 Mar; 190(3):896-906. PubMed ID: 31515672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of EBAF in the heart with ventricular septal defects and its regulation by histone acetyltransferase p300 and transcription factors smad2 and cited2.
    Su D; Li Q; Guan L; Gao X; Zhang H; Dandan E; Zhang L; Ma X
    Biochim Biophys Acta; 2013 Dec; 1832(12):2145-52. PubMed ID: 23899608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional significance of novel variants of the MEF2C gene promoter in congenital ventricular septal defects.
    Zeng ZH; Chen HX; Liu XC; Yang Q; He GW
    Am J Med Genet A; 2022 Aug; 188(8):2397-2405. PubMed ID: 35719119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiological Role of Variants of the Promoter Region of CITED2 Gene in Sporadic Tetralogy of Fallot Patients with Cellular Function Verification.
    Chen Z; Chen HX; Hou HT; Yin XY; Yang Q; He GW
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A HAND2 Loss-of-Function Mutation Causes Familial Ventricular Septal Defect and Pulmonary Stenosis.
    Sun YM; Wang J; Qiu XB; Yuan F; Li RG; Xu YJ; Qu XK; Shi HY; Hou XM; Huang RT; Xue S; Yang YQ
    G3 (Bethesda); 2016 Apr; 6(4):987-92. PubMed ID: 26865696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variations of CITED2 are associated with congenital heart disease (CHD) in Chinese population.
    Liu Y; Wang F; Wu Y; Tan S; Wen Q; Wang J; Zhu X; Wang X; Li C; Ma X; Pan H
    PLoS One; 2014; 9(5):e98157. PubMed ID: 24848765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and functional analysis of CITED2 mutations in patients with congenital heart defects.
    Sperling S; Grimm CH; Dunkel I; Mebus S; Sperling HP; Ebner A; Galli R; Lehrach H; Fusch C; Berger F; Hammer S
    Hum Mutat; 2005 Dec; 26(6):575-82. PubMed ID: 16287139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mutation analysis of Cited2 in patients with congenital heart disease].
    Yang XF; Wu XY; Li M; Li YG; Dai JT; Bai YH; Tian J
    Zhonghua Er Ke Za Zhi; 2010 Apr; 48(4):293-6. PubMed ID: 20654020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and Functional Verification of CITED2 Gene Promoter Region in Patients with Patent Ductus Arteriosus.
    Chen Z; Chen HX; Hou HT; Yin XY; Yang Q; He GW
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NOTCH1 Gene MicroRNA Target Variation and Ventricular Septal Defect Risk.
    Ji L; Hou H; Zhu K; Liu X; Liu Y; Wang Q; Li J; Liu H; Zhang Q; Lv J; Alexander R; Wang W; Li D
    OMICS; 2019 Jan; 23(1):28-35. PubMed ID: 30629480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic analysis of the TBX1 gene promoter in ventricular septal defects.
    Wang H; Chen D; Ma L; Meng H; Liu Y; Xie W; Pang S; Yan B
    Mol Cell Biochem; 2012 Nov; 370(1-2):53-8. PubMed ID: 22801995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and functional analysis of variants of MYH6 gene promoter in isolated ventricular septal defects.
    Zuo JY; Chen HX; Liu ZG; Yang Q; He GW
    BMC Med Genomics; 2022 Oct; 15(1):213. PubMed ID: 36209093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of DARS gene polymorphisms with the risk of isolated ventricular septal defects in the Chinese Han population.
    Feng Y; Chen R; Mo X
    Ital J Pediatr; 2016 Nov; 42(1):102. PubMed ID: 27871331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Genetic Study on HAND2 Gene Promoter in Ventricular Septal Defect.
    Li M; Cai Y; Pang S; Yan B
    Int Heart J; 2023; 64(6):1140-1147. PubMed ID: 38030295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Variants of
    Chen Z; Chen HX; Hou HT; Yin XY; Yang Q; Han J; He GW
    J Cardiovasc Dev Dis; 2022 Sep; 9(10):. PubMed ID: 36286273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and functional analysis of the NKX2-5 gene promoter in patients with ventricular septal defects.
    Pang S; Shan J; Qiao Y; Ma L; Qin X; Wanyan H; Xing Q; Wu G; Yan B
    Pediatr Cardiol; 2012 Dec; 33(8):1355-61. PubMed ID: 22576768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic analysis of the promoter region of the GATA4 gene in patients with ventricular septal defects.
    Wu G; Shan J; Pang S; Wei X; Zhang H; Yan B
    Transl Res; 2012 May; 159(5):376-82. PubMed ID: 22500510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CITED2 mutation and methylation in children with congenital heart disease.
    Xu M; Wu X; Li Y; Yang X; Hu J; Zheng M; Tian J
    J Biomed Sci; 2014 Jan; 21(1):7. PubMed ID: 24456003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.